Xilio Therapeutics
32 hedge funds and large institutions have $41.9M invested in Xilio Therapeutics in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
18% less capital invested
Capital invested by funds: $51M → $41.9M (-$9.05M)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Holders
32
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$31.2K | |
| 2 | +$3.92K | |
| 3 | +$2.36K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$2.15K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$8 |
Top Sellers
| 1 | -$153K | |
| 2 | -$54K | |
| 3 | -$10.1K | |
| 4 |
Morgan Stanley
New York
|
-$9.23K |
| 5 |
BlackRock
New York
|
-$4.7K |